{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T18:14:00Z","timestamp":1793988840625,"version":"4.8.0"},"reference-count":64,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Arora Family Foundation, Cleveland, Ohio, USA","award":["none"],"award-info":[{"award-number":["none"]}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"crossref","award":["Merit 1I01BX000357 and RCS IK6BX005646"],"award-info":[{"award-number":["Merit 1I01BX000357 and RCS IK6BX005646"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ruth M. Kraeuchi Endowed Chair Ophthalmology Fund, University of Missouri, Columbia, Missouri, USA.","award":["none"],"award-info":[{"award-number":["none"]}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"crossref","award":["1R01EY030774"],"award-info":[{"award-number":["1R01EY030774"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ocular Pharmacology and Therapeutics"],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>\n                      Rho-associated kinase (ROCK) regulates fibrosis and angiogenesis. This study evaluated the effects of the topical ROCK inhibitor HA1077 (fasudil) to attenuate corneal fibrosis and corneal neovascularization (CNV)\n                      <jats:italic toggle=\"yes\">in\u00a0vivo<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Primary human corneal stromal fibroblasts (hCSF) and New Zealand White rabbits (n = 12) were used. Corneal fibrosis and CNV\n                      <jats:italic toggle=\"yes\">in\u00a0vivo<\/jats:italic>\n                      were provoked by alkali injury. Immediately post-injury, eyes received topical balanced salt solution (BSS) or HA1077 (3 nM twice\/day for 3 days). Clinical slit-lamp biomicroscopy and stereomicroscopy gauged corneal haze\/fibrosis (Fante\u2019s score) and CNV (morphometric score) in live rabbits. Post-euthanasia, H&amp;E, immunofluorescence, and terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assays analyzed \u03b1-smooth muscle actin (\u03b1-SMA), filamentous actin (F-actin), endoglin, CD11b, and apoptotic cells.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      HA1077 treatment to hCSF did not alter viability, morphology, and proliferation ability at 3 nM or lower doses. Topical HA1077 (3 nM) treatment significantly reduced corneal haze\/fibrosis (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.0001) and CNV (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.0001)\n                      <jats:italic toggle=\"yes\">in\u00a0vivo<\/jats:italic>\n                      at days 7 and 14 compared with the corresponding controls. Histological H&amp;E analysis revealed retrieval of overall corneal health with a remarkable decrease in fibrotic (myofibroblasts), angiogenic (neovessels), and immune cell infiltration in rabbit corneas treated with HA1077 than the control corneas. HA1077 therapy significantly reduced \u03b1-SMA\n                      <jats:sup>+<\/jats:sup>\n                      , F-actin\n                      <jats:sup>+<\/jats:sup>\n                      , and endoglin\n                      <jats:sup>+<\/jats:sup>\n                      cells, markers of fibrosis and CNV. Intraocular pressure (IOP) remained within the normal physiological range of eyes with HA1077. TUNEL assay revealed the tolerability of the examined HA1077 regimen\n                      <jats:italic toggle=\"yes\">in\u00a0vivo<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>\n                      The tested HA1077 dosage regimen is effective and tolerable to rabbit eyes in abrogating corneal fibrosis and CNV triggered by alkali injury\n                      <jats:italic toggle=\"yes\">in\u00a0vivo<\/jats:italic>\n                      without major adverse effects. ROCK inhibition represents a promising therapeutic strategy for vascularized and fibrotic corneal wounds but warrants additional dose\u2013response\n                      <jats:italic toggle=\"yes\">in\u00a0vivo<\/jats:italic>\n                      studies.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10807683251405622","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T12:23:37Z","timestamp":1767097417000},"page":"235-243","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Topical Rho-Associated Protein Kinase Inhibitor HA1077 Reduces Rabbit Corneal Fibrosis and Neovascularization\n                    <i>In Vivo<\/i>"],"prefix":"10.1177","volume":"42","author":[{"given":"Michael K.","family":"Fink","sequence":"first","affiliation":[{"name":"Harry S. Truman Memorial Veterans\u2019 Hospital, Columbia, Missouri, USA."},{"name":"Departments of Veterinary Medicine &amp; Surgery and Pathobiology and Integrative Biomedical Sciences, University of Missouri, Columbia, Missouri, USA."},{"name":"Department of Pathology, School of Medicine, University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suneel","family":"Gupta","sequence":"additional","affiliation":[{"name":"Harry S. Truman Memorial Veterans\u2019 Hospital, Columbia, Missouri, USA."},{"name":"Departments of Veterinary Medicine &amp; Surgery and Pathobiology and Integrative Biomedical Sciences, University of Missouri, Columbia, Missouri, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajnish","family":"Kumar","sequence":"additional","affiliation":[{"name":"Harry S. Truman Memorial Veterans\u2019 Hospital, Columbia, Missouri, USA."},{"name":"Departments of Veterinary Medicine &amp; Surgery and Pathobiology and Integrative Biomedical Sciences, University of Missouri, Columbia, Missouri, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant R.","family":"Sinha","sequence":"additional","affiliation":[{"name":"Harry S. Truman Memorial Veterans\u2019 Hospital, Columbia, Missouri, USA."},{"name":"Departments of Veterinary Medicine &amp; Surgery and Pathobiology and Integrative Biomedical Sciences, University of Missouri, Columbia, Missouri, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn M.","family":"Martin","sequence":"additional","affiliation":[{"name":"Harry S. Truman Memorial Veterans\u2019 Hospital, Columbia, Missouri, USA."},{"name":"Departments of Veterinary Medicine &amp; Surgery and Pathobiology and Integrative Biomedical Sciences, University of Missouri, Columbia, Missouri, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Landreneau","sequence":"additional","affiliation":[{"name":"Harry S. Truman Memorial Veterans\u2019 Hospital, Columbia, Missouri, USA."},{"name":"Mason Eye Institute, Department of Ophthalmology, School of Medicine, University of Missouri, Columbia, Missouri, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv R.","family":"Mohan","sequence":"additional","affiliation":[{"name":"Harry S. Truman Memorial Veterans\u2019 Hospital, Columbia, Missouri, USA."},{"name":"Departments of Veterinary Medicine &amp; Surgery and Pathobiology and Integrative Biomedical Sciences, University of Missouri, Columbia, Missouri, USA."},{"name":"Mason Eye Institute, Department of Ophthalmology, School of Medicine, University of Missouri, Columbia, Missouri, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2024.01.001"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1039\/d5tb00624d"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1159\/000345451"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.146052"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jevs.2024.105002"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjo.2024.04.001"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-012-1988-6"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2017.08.001"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2023.05.007"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-020-1026-6"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/196827"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0b013e32833a8da2"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.122.4.477"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6701973"},{"key":"e_1_3_3_16_2","first-page":"448","article-title":"Analysis of Smad3 in the modulation of stromal extracellular matrix proteins in corneal scarring after alkali injury","volume":"30","author":"Gupta S","year":"2024","unstructured":"Gupta S, , Zhang E, , Sinha S, et al. Analysis of Smad3 in the modulation of stromal extracellular matrix proteins in corneal scarring after alkali injury. Mol Vis, 2024; 30:448\u2013464.","journal-title":"Mol Vis"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25105479"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2022.101090"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells13181532"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2018.06.004"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v11.i30.7337"},{"issue":"11","key":"e_1_3_3_22_2","first-page":"3645","article-title":"Rho kinase proteins\u2013pleiotropic modulators of cell survival and apoptosis","volume":"31","author":"Street CA","year":"2011","unstructured":"Street CA, , Bryan BA. Rho kinase proteins\u2013pleiotropic modulators of cell survival and apoptosis. Anticancer Res, 2011; 31(11):3645\u20133657.","journal-title":"Anticancer Res"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrm1128"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2004.05.005"},{"issue":"4","key":"e_1_3_3_25_2","first-page":"978","article-title":"Rho and Rho-kinase (ROCK) signaling in adherens and gap junction assembly in corneal epithelium","volume":"43","author":"Anderson SC","year":"2002","unstructured":"Anderson SC, , Stone C, , Tkach L, et al. Rho and Rho-kinase (ROCK) signaling in adherens and gap junction assembly in corneal epithelium. Invest Ophthalmol Vis Sci, 2002; 43(4):978\u2013986.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.03-1218"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.07-1122"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceb.2008.01.002"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-014-0333-2"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(00)00059-3"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.163.1.2001089"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0014-2999(02)02619-5"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfr012"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2008.07.038"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13081871"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.2165\/00063030-200721030-00004"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-024-03342-4"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000000493"},{"key":"e_1_3_3_39_2","first-page":"688","article-title":"Fasudil hydrochloride, a potent ROCK inhibitor, inhibits corneal neovascularization after alkali burns in mice","volume":"21","author":"Zeng P","year":"2015","unstructured":"Zeng P, , Pi RB, , Li P, et al. Fasudil hydrochloride, a potent ROCK inhibitor, inhibits corneal neovascularization after alkali burns in mice. Mol Vis, 2015; 21:688\u2013698.","journal-title":"Mol Vis"},{"key":"e_1_3_3_40_2","first-page":"1727","article-title":"A selective inhibitor of the Rho kinase pathway, Y-27632, and its influence on wound healing in the corneal stroma","volume":"18","author":"Yamamoto M","year":"2012","unstructured":"Yamamoto M, , Quantock AJ, , Young RD, et al. A selective inhibitor of the Rho kinase pathway, Y-27632, and its influence on wound healing in the corneal stroma. Mol Vis, 2012; 18:1727\u20131739.","journal-title":"Mol Vis"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.08-3276"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.90624.2007"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.15-17595"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.17-23308"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2019.107705"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1990.01070070051034"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026432"},{"key":"e_1_3_3_48_2","volume-title":"AVMA Guidelines for the Euthanasia of Animals","author":"Leary SUW","year":"2020","unstructured":"Leary SUW, , Anthony R, , Cartner S, et al. AVMA Guidelines for the Euthanasia of Animals: 2020 Edition. AVMA; 2020.","edition":"2020"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.15-18750"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-006-0389-y"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2013.03.012"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00005-007-0009-7"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.110.223172"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1097\/PRS.0b013e31822b7352"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00060.2014"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-06-0689"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.09-145102"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2014.2471"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111748"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.294967"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.7.6.6"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2010.05.013"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.11-7357"},{"key":"e_1_3_3_64_2","first-page":"2598","article-title":"Attenuation of corneal myofibroblast development through nanoparticle-mediated soluble transforming growth factor-beta type II receptor (sTGFbetaRII) gene transfer","volume":"18","author":"Sharma A","year":"2012","unstructured":"Sharma A, , Rodier JT, , Tandon A, et al. Attenuation of corneal myofibroblast development through nanoparticle-mediated soluble transforming growth factor-beta type II receptor (sTGFbetaRII) gene transfer. Mol Vis, 2012; 18:2598\u20132607.","journal-title":"Mol Vis"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066434"}],"container-title":["Journal of Ocular Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10807683251405622","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10807683251405622","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10807683251405622","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T10:19:15Z","timestamp":1787134755000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10807683251405622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,5,1]]}},"alternative-id":["10.1177\/10807683251405622"],"URL":"https:\/\/doi.org\/10.1177\/10807683251405622","relation":{},"ISSN":["1080-7683","1557-7732"],"issn-type":[{"value":"1080-7683","type":"print"},{"value":"1557-7732","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]}}}